Dna encoding the human serine protease eos
CA 2383601 A1 · Owner: Ortho-Mcneil Pharmaceutical, Inc. · Inventors: Darrow, Andrew L.; Andrade-Gordon, Patricia; Chen, Cailin
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Here we describe the molecular identification of a cDNA encoding a novel serine protease we have termed protease EOS. The deduced amino acid sequence and its alignment with other well-characterized serine proteases clearly indicates that it is a member of the S1 serine protease family. We have found that the protease EOS mRNA is expressed in platelets and leukocytes and more specifically eosinophils and possibly macrophages. Although this protease is abundantly expressed in ovary, retina and stomach where it may perform , important functions its expression in platelets and certain cells of the immune system suggests that it may play roles in thrombosis and in the immune process. …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 18, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 18, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 18, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.